Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions

Naomi Schlesinger; Rieke E Alten; Thomas Bardin; H Ralph Schumacher; Mark Bloch; Alberto Gimona; Gerhard Krammer; Valda Murphy; Dominik Richard; Alexander K So

doi:10.1136/annrheumdis-2011-200908

Article info

Clinical and epidemiological research

Extended report

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions

Authors

Naomi Schlesinger University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA PubMed articles Google scholar articles
Rieke E Alten Department of Internal Medicine, Rheumatology, Schlosspark-Klinik, Charité University Medicine, Berlin, Germany PubMed articles Google scholar articles
Thomas Bardin Service de Rhumatologie, Hôpital Lariboisière, and University Paris VII, Paris, France PubMed articles Google scholar articles
H Ralph Schumacher Department of Medicine, and VA Medical Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA PubMed articles Google scholar articles
Mark Bloch Holdsworth House Medical Practice, Sydney, Australia PubMed articles Google scholar articles
Alberto Gimona Departments of Integrated Hospital Care Franchise and Integrated Information Sciences, Novartis Pharma AG, Basel, Switzerland PubMed articles Google scholar articles
Gerhard Krammer Departments of Integrated Hospital Care Franchise and Integrated Information Sciences, Novartis Pharma AG, Basel, Switzerland PubMed articles Google scholar articles
Valda Murphy Departments of Integrated Hospital Care Franchise and Integrated Information Sciences, Novartis Pharma AG, Basel, Switzerland PubMed articles Google scholar articles
Dominik Richard Departments of Integrated Hospital Care Franchise and Integrated Information Sciences, Novartis Pharma AG, Basel, Switzerland PubMed articles Google scholar articles
Alexander K So Department of Rheumatology, University Hospital of Lausanne, Lausanne, Switzerland PubMed articles Google scholar articles

Correspondence to Professor Naomi Schlesinger, Division of Rheumatology, Department of Medicine, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA; schlesna{at}umdnj.edu

View Full Text

Citation

Schlesinger N, Alten RE, Bardin T, et al

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions

Annals of the Rheumatic Diseases 2012;71:1839-1848.

Publication history

Accepted February 26, 2012
First published May 14, 2012.

Online issue publication

October 31, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password